0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Original Investigation |

Factors Associated With Mortality in Pediatric vs Adult Nasopharyngeal Carcinoma

Morgan K. Richards, MD, MPH1,2; John P. Dahl, MD, PhD, MBA3; Kenneth Gow, MD2; Adam B. Goldin, MD, MPH2; John Doski, MD4; Melanie Goldfarb, MD5; Jed Nuchtern, MD6; Monica Langer, MD7; Elizabeth A. Beierle, MD8; Sanjeev Vasudevan, MD6; Douglas S. Hawkins, MD9; Sanjay R. Parikh, MD3
[+] Author Affiliations
1Department of Surgery, University of Washington, Seattle
2Division of Pediatric General and Thoracic Surgery, Department of General and Thoracic Surgery, Seattle Children’s Hospital, Seattle, Washington
3Department of Otolaryngology—Head and Neck Surgery, University of Washington, Seattle
4Division of Pediatric Surgery, Methodist Children’s Hospital of South Texas, San Antonio
5Department of Surgery, John Wayne Cancer Institute, Santa Monica, California
6Division of Pediatric Surgery, Baylor College of Medicine, Houston, Texas
7Department of Pediatric General Surgery, Maine Children’s Cancer Program, Portland
8Department of Pediatric General Surgery, University of Alabama, Birmingham
9Fred Hutchinson Cancer Research Center, Department of Pediatrics, Seattle Children’s Hospital, University of Washington, Seattle
JAMA Otolaryngol Head Neck Surg. 2016;142(3):217-222. doi:10.1001/jamaoto.2015.3217.
Text Size: A A A
Published online

Importance  Nasopharyngeal carcinoma (NPC) is endemic in some Asian regions but is uncommon in the United States. Little is known about the racial, demographic, and biological characteristics of the disease in pediatric patients.

Objectives  To improve understanding of the differences between pediatric and adult NPC and to determine whether race conferred a survival difference among pediatric patients with NPC.

Design, Setting, and Participants  This retrospective cohort study included all 17 317 patients with a primary diagnosis of NCP in the National Cancer Data Base from January 1, 1998, to December 31, 2011. Of these, 699 patients were 21 years or younger (pediatric); 16 618 patients, older than 21 years (adult). Data were analyzed after data collection.

Exposure  Pediatric age at diagnosis of NPC.

Main Outcomes and Measures  Demographic, tumor, and treatment characteristics of pediatric patients with NPC were compared with those of adults using the χ2 test for categorical variables. An adjusted Cox proportional hazards regression model was used to examine survival differences in pediatric patients relative to adult patients. In addition, the risk for pediatric mortality by race was estimated.

Results  Of the 17 317 patients, a total of 699 pediatric and 16 618 adult patients were identified with a primary diagnosis of NPC (female, 239 pediatric patients [34.2%] and 5153 adult patients [32.4%]). Pediatric patients were most commonly black (299 of 686 [43.6%]), whereas adults were most likely to be non-Hispanic white (9839 of 16 504 [60.0%]; P < .001). Pediatric patients were less likely to be Asian (39 of 686 [5.7%]) than were adults (3226 of 16 405 [19.7%]; P < .001). Pediatric patients were more likely to have regional nodal evaluation and to present with stage IV disease (227 of 643 [35.3%] and 330 of 565 [58.4%], respectively) than were adult patients (3748 of 15 631 [24.0%] and 6553 of 13 721 [47.8%], respectively; P < .001 for both comparisons). Pediatric patients had a lower risk for mortality relative to adults (hazard ratio, 0.37; 95% CI, 0.25-0.56). No difference in mortality by racial group was found among pediatric patients (hazard ratio, 1.10; 95% CI, 0.82-1.40).

Conclusions and Relevance  Pediatric patients with NPC were more commonly black and presented more frequently with stage IV disease. Pediatric patients had a decreased mortality risk relative to adults, even after adjusting for covariables. Asian race was not associated with increased mortality in pediatric patients with NPC. Racial differences are not associated with an increased risk for mortality among pediatric patients.

Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Figures

Place holder to copy figure label and caption
Figure 1.
Kaplan-Meier Survival Estimates for Pediatric and Adult Patients With Nasopharyngeal Carcinoma

Pediatric patients include those 21 years or younger; adult patients, older than 21 years.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.
Kaplan-Meier Survival Estimates for Pediatric Patients With Nasopharyngeal Carcinoma by Race

Pediatric patients include those 21 years or younger.

Graphic Jump Location

Tables

References

Correspondence

CME


You need to register in order to view this quiz.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

586 Views
0 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
Jobs
brightcove.createExperiences();